The sudden popularity of drugs like Ozempic and Wegovy for weight loss created a multibillion-dollar market overnight. Healthcare companies want a piece of it.
The weight-loss space is quickly maturing into a booming pharmaceutical segment like those for cancer and heart disease. Investors are making bets on the next breakthrough product and drugmakers are racing to test dozens of new therapies. Companies are developing diagnostic tests that could better match patients to drugs best suited for them.
